We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q3 Potential of Fortive (FTV): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Fortive (FTV - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.93 per share, reflecting an increase of 9.4% compared to the same period last year. Revenues are forecasted to be $1.55 billion, representing a year-over-year increase of 3.6%.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Fortive metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Sales- Intelligent Operating Solutions' to come in at $680.57 million. The estimate indicates a change of +5.6% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Sales- Advanced Healthcare Solutions' of $314.27 million. The estimate suggests a change of -1.7% year over year.
The consensus estimate for 'Sales- Precision Technologies' stands at $552.71 million. The estimate indicates a year-over-year change of +4.2%.
The combined assessment of analysts suggests that 'Adjusted Operating Profit (Non-GAAP)- Precision Technologies' will likely reach $141.44 million. Compared to the current estimate, the company reported $140.50 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Adjusted Operating Profit (Non-GAAP)- Intelligent Operating Solutions' should arrive at $225.54 million. The estimate compares to the year-ago value of $206 million.
It is projected by analysts that the 'Adjusted Operating Profit (Non-GAAP)- Advanced Healthcare Solutions' will reach $80.23 million. The estimate is in contrast to the year-ago figure of $71.90 million.
Over the past month, Fortive shares have recorded returns of -5.3% versus the Zacks S&P 500 composite's +2% change. Based on its Zacks Rank #3 (Hold), FTV will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unlocking Q3 Potential of Fortive (FTV): Exploring Wall Street Estimates for Key Metrics
In its upcoming report, Fortive (FTV - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.93 per share, reflecting an increase of 9.4% compared to the same period last year. Revenues are forecasted to be $1.55 billion, representing a year-over-year increase of 3.6%.
Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
That said, let's delve into the average estimates of some Fortive metrics that Wall Street analysts commonly model and monitor.
Analysts expect 'Sales- Intelligent Operating Solutions' to come in at $680.57 million. The estimate indicates a change of +5.6% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Sales- Advanced Healthcare Solutions' of $314.27 million. The estimate suggests a change of -1.7% year over year.
The consensus estimate for 'Sales- Precision Technologies' stands at $552.71 million. The estimate indicates a year-over-year change of +4.2%.
The combined assessment of analysts suggests that 'Adjusted Operating Profit (Non-GAAP)- Precision Technologies' will likely reach $141.44 million. Compared to the current estimate, the company reported $140.50 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'Adjusted Operating Profit (Non-GAAP)- Intelligent Operating Solutions' should arrive at $225.54 million. The estimate compares to the year-ago value of $206 million.
It is projected by analysts that the 'Adjusted Operating Profit (Non-GAAP)- Advanced Healthcare Solutions' will reach $80.23 million. The estimate is in contrast to the year-ago figure of $71.90 million.
View all Key Company Metrics for Fortive here>>>
Over the past month, Fortive shares have recorded returns of -5.3% versus the Zacks S&P 500 composite's +2% change. Based on its Zacks Rank #3 (Hold), FTV will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>